Immunohistochemistry Industry

The global immunohistochemistry market size was valued at USD 2.33 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2023 to 2030. Increasing implementation of automation and machine learning in immunohistochemistry (IHC), coupled with the introduction of technologically advanced immunohistochemistry solutions, is expected to significantly drive the market throughout the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced immunohistochemistry systems for disease diagnosis are further propelling the market growth.

For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Companies continue to launch novel products to strengthen their market position, which leads to revenue generation. For instance, in March 2021, Roche launched the DISCOVERY Green HRP kit to detect and profile biomarkers and cell populations in tissue-based research. This kit can be utilized in combination with other detection kits, expanding the multiplexing capacity of in situ hybridization and immunohistochemistry. Similarly, in March 2023, Paige announced the inclusion of artificial intelligence (AI) algorithms of Mindpeak's for immunohistochemistry biomarker quantification on the company’s platform. Mindpeak, a software company specializing in image analysis, has contributed AI algorithms designed for the analysis of immunohistochemistry slides of lung and breast tissue, which are now available on the platform. IHC technology is limited to single parametric evaluations of a sample.

Gather more insights about the market drivers, restrains and growth of the Global Immunohistochemistry market

Immunohistochemistry Market Segments Highlights:

Product Insights

The antibodies segment dominated the market in 2022 and accounted for the largest share of 40.96% owing to the vital usage of antibodies in disease diagnosis and drug testing. The monoclonal antibodies and antibody-related products such as Fc-fusion, antibody fragments, and antibody-drug conjugates have become the dominating product class in terms of usage rate. The antibodies are applied across a wide range of applications such as pathology, neuropathology, and hematopathology.

Application Insights

Based on applications, the global market has been further bifurcated into diagnostics and research segments. The diagnostics application segment accounted for the largest revenue share of more than 69.16% in 2022 and is anticipated to maintain its lead over the forecast period. Immunohistochemistry (IHC) tests are widely used for the diagnosis of a wide range of chronic conditions, such as cancer, cardiovascular diseases, infectious diseases, diabetes mellitus, autoimmune diseases, and nephrological diseases. Furthermore, the growing prevalence of chronic diseases is anticipated to drive the diagnostics segment.

End-use Insights

Based on end-uses, the global market has been further sub-segmented into hospitals & diagnostic laboratories, research institutes, and others. In 2022, the hospitals and diagnostic laboratories segment dominated the market and accounted for the largest share of more than 70.76% of the overall revenue. This growth was attributed to the high volume of IHC tests carried out in hospital settings. Furthermore, with the constant changes in the healthcare industry, the need for hospitals with advanced facilities has also increased. This, in turn, is also expected to increase the revenue flow in this segment.

Regional Insights

Based on region, the global market has been further sub-categorized into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 and accounted for the largest share of more than 38.39%. of the global revenue. Key factors contributing to the regional market growth include the presence of major market players, easy availability of IHC solutions, higher adoption of technologically advanced IHC instruments, and entry of newer IHC solutions.

Browse through Grand View Research's Biotechnology Industry Research Reports.

1. The global machine learning market size was valued at USD 36.73 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 34.8% from 2023 to 2030.

2. The global monoclonal antibodies market size was valued at USD 210.06 billion in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 11.04% from 2023 to 2030.

Key Companies & Market Share Insights

With the rising demand for IHC assays in cancer diagnostics, the key players are undertaking various strategic initiatives in the field of immunohistochemistry, including new product launches, mergers & acquisitions, and regional expansion, to meet the market needs.

For instance, in March 2023, Aptamer Group launched a new reagent solution, Optimer-Fc for use in automated immunohistochemistry workflows. The company expects this launch to open new avenues for emerging biomarkers in diagnostics and research. In addition, in January 2021, Abcam and Shuwen Biotech (Shuwen) entered into a strategic alliance for developing and commercializing companion diagnostics (CDx). Under the agreement, Abcam is providing recombinant rabbit monoclonal antibodies to Shuwen Biotech for further immunohistochemical verification. Some prominent players in the global immunohistochemistry market include:

1. Thermo Fisher Scientific Inc.

2. Hoffmann-La Roche Ltd.

3. Merck KGaA

4. Danaher Corporation

5. Perkinelmer, Inc.

6. Bio-Rad Laboratories, Inc.

7. Cell Signaling Technology, Inc.

8. Bio SB

9. Agilent Technologies, Inc.

10. Abcam plc.

Segments Covered in the Report

Grand View Research has segmented the global immunohistochemistry market based on product, application, end-use, and region:

Immunohistochemistry Product Outlook (Revenue, USD Million, 2018 - 2030)

1. Antibodies

   1. Primary Antibodies

   2. Secondary Antibodies

2. Equipment

   1. Slide Staining System

   2. Tissue Microarrays

   3. Tissue Processing Systems

   4. Slide Scanners

   5. Others

3. Reagents

   1. Histological stains

   2. Blocking Sera & Reagents

   3. Chromogenic Substrates

   4. Fixation Reagents

   5. Organic Solvents

   6. Proteolytic Enzymes

   7. Diluents

   8. Other Reagents

4. Kits

Immunohistochemistry Application Outlook (Revenue, USD Million, 2018 - 2030)

1. Diagnostics

   1. Cancer

   2. Infectious Diseases

   3. Cardiovascular Diseases

   4. Autoimmune Diseases

   5. Diabetes Mellitus

   6. Nephrological Diseases

2. Research

Immunohistochemistry End-use Outlook (Revenue, USD Million, 2018 - 2030)

1. Hospitals & Diagnostic Laboratories

2. Research Institutes

3. Others

Immunohistochemistry Regional Outlook (Revenue, USD Million, 2018 - 2030)

1. North America

   1. US

   2. Canada

2. Europe

   1. Germany

   2. UK

   3. France

   4. Italy

   5. Spain

   6. Denmark

   7. Sweden

   8. Norway

3. Asia Pacific

   1. Japan

   2. China

   3. India

   4. South Korea

   5. Australia

   6. Thailand

4. Latin America

   1. Brazil

   2. Mexico

   3. Argentina

5. Middle East & Africa

   1. South Africa

   2. Saudi Arabia

   3. UAE

   4. Kuwait

Order a free sample PDF of the Immunohistochemistry Market Intelligence Study, published by Grand View Research.